Iovance Biotherapeutics, Inc.

IOVA stock score: 52/100

$14.14 · -3.28% · Scored Oct 22, 2026

Technical
65
Fundamental
39
News
45

The reading

Iovance Biotherapeutics (IOVA) scores 52 out of 100, which reads neutral, higher than 68% of Healthcare stocks and 49% of the 4,161 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 65, fundamentals 39.

Among the fundamentals, Revenue Growth (5-Year) at 100 and Insider Transactions at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 65 and contrarian oscillators 38 — a split worth reading before trusting the technical total.

News sentiment is neutral at 45; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 46 to 67, and it is down 15 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward IOVA’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

39

Pulling it up

  • Revenue Growth (5-Year)100

    5-year revenue growth analyzes long-term sales trajectory and consistency.

  • Insider Transactions100

    Insider transactions track recent buying and selling by company insiders.

  • Revenue Growth (Annual)100

    Annual revenue growth tracks year-over-year sales expansion.

Holding it back

  • Earnings Profitability (Quarterly)0

    Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

  • Operating Margins0

    Operating margins measure profitability after operating expenses.

40 weighted scorers; 1 had no data today and are left out rather than counted as zero.

Technical · daily

63

Pulling it up

  • Parabolic SAR (PSAR)100

    Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • EMA 50100

    Exponential Moving Average (50-period) is a key intermediate-term trend indicator that responds more quickly than SMA-50.

  • SMA 50100

    Simple Moving Average (50-period) is a widely-watched intermediate-term trend gauge.

Holding it back

  • Candlestick Patterns0

    Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Stock Volatility5

    Stock volatility measures price fluctuation magnitude over time.

  • Percentage Price Oscillator (PPO)12

    Percentage Price Oscillator shows the difference between two moving averages as a percentage.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
45

Technical score by timeframe

ChartScoreWeight
Hourly441
Daily633
Weekly732
Monthly682
Quarterly672

Composite score, last 90 days

05010052Jul 25, 2026Oct 22, 2026Jul 25, 2026: 67Jul 26, 2026: 67Jul 27, 2026: 66Jul 28, 2026: 66Jul 29, 2026: 52Jul 30, 2026: 53Jul 31, 2026: 50Aug 2, 2026: 46Aug 3, 2026: 47Aug 5, 2026: 48Aug 6, 2026: 53Aug 7, 2026: 53Aug 8, 2026: 53Aug 9, 2026: 53Aug 10, 2026: 54Aug 11, 2026: 54Aug 12, 2026: 54Aug 13, 2026: 54Aug 14, 2026: 55Aug 15, 2026: 55Aug 16, 2026: 55Aug 17, 2026: 55Aug 18, 2026: 54Aug 19, 2026: 56Aug 20, 2026: 56Aug 22, 2026: 53Aug 23, 2026: 53Aug 24, 2026: 53Aug 25, 2026: 53Aug 26, 2026: 53Aug 27, 2026: 53Aug 28, 2026: 52Aug 29, 2026: 53Aug 30, 2026: 53Aug 31, 2026: 53Sep 1, 2026: 53Sep 2, 2026: 54Sep 3, 2026: 54Sep 4, 2026: 54Sep 5, 2026: 53Sep 6, 2026: 53Sep 7, 2026: 54Sep 8, 2026: 53Sep 9, 2026: 51Sep 10, 2026: 50Sep 11, 2026: 53Sep 12, 2026: 52Sep 13, 2026: 52Sep 14, 2026: 54Sep 15, 2026: 53Sep 16, 2026: 53Sep 17, 2026: 53Sep 18, 2026: 53Sep 19, 2026: 53Sep 20, 2026: 53Sep 21, 2026: 53Sep 22, 2026: 54Sep 23, 2026: 52Sep 24, 2026: 54Sep 25, 2026: 53Sep 26, 2026: 53Sep 27, 2026: 53Sep 28, 2026: 53Sep 29, 2026: 55Sep 30, 2026: 55Oct 1, 2026: 54Oct 2, 2026: 54Oct 3, 2026: 54Oct 4, 2026: 54Oct 5, 2026: 54Oct 6, 2026: 53Oct 7, 2026: 53Oct 8, 2026: 54Oct 9, 2026: 55Oct 10, 2026: 55Oct 11, 2026: 55Oct 12, 2026: 56Oct 13, 2026: 55Oct 14, 2026: 54Oct 15, 2026: 54Oct 16, 2026: 52Oct 17, 2026: 52Oct 18, 2026: 52Oct 19, 2026: 53Oct 20, 2026: 54Oct 21, 2026: 54Oct 22, 2026: 52
Show the daily numbers
DateComposite
Oct 22, 202652
Oct 21, 202654
Oct 20, 202654
Oct 19, 202653
Oct 18, 202652
Oct 17, 202652
Oct 16, 202652
Oct 15, 202654
Oct 14, 202654
Oct 13, 202655
Oct 12, 202656
Oct 11, 202655
Oct 10, 202655
Oct 9, 202655
Oct 8, 202654
Oct 7, 202653
Oct 6, 202653
Oct 5, 202654
Oct 4, 202654
Oct 3, 202654
Oct 2, 202654
Oct 1, 202654
Sep 30, 202655
Sep 29, 202655
Sep 28, 202653
Sep 27, 202653
Sep 26, 202653
Sep 25, 202653
Sep 24, 202654
Sep 23, 202652
Sep 22, 202654
Sep 21, 202653
Sep 20, 202653
Sep 19, 202653
Sep 18, 202653
Sep 17, 202653
Sep 16, 202653
Sep 15, 202653
Sep 14, 202654
Sep 13, 202652
Sep 12, 202652
Sep 11, 202653
Sep 10, 202650
Sep 9, 202651
Sep 8, 202653
Sep 7, 202654
Sep 6, 202653
Sep 5, 202653
Sep 4, 202654
Sep 3, 202654
Sep 2, 202654
Sep 1, 202653
Aug 31, 202653
Aug 30, 202653
Aug 29, 202653
Aug 28, 202652
Aug 27, 202653
Aug 26, 202653
Aug 25, 202653
Aug 24, 202653
Aug 23, 202653
Aug 22, 202653
Aug 20, 202656
Aug 19, 202656
Aug 18, 202654
Aug 17, 202655
Aug 16, 202655
Aug 15, 202655
Aug 14, 202655
Aug 13, 202654
Aug 12, 202654
Aug 11, 202654
Aug 10, 202654
Aug 9, 202653
Aug 8, 202653
Aug 7, 202653
Aug 6, 202653
Aug 5, 202648
Aug 3, 202647
Aug 2, 202646
Jul 31, 202650
Jul 30, 202653
Jul 29, 202652
Jul 28, 202666
Jul 27, 202666
Jul 26, 202667
Jul 25, 202667

Key facts

Market cap
$6.4B
Sector
Healthcare
Industry
Biotechnology
Beta
0.76
Risk grade (1–10)
8
Next earnings
Nov 5, 2026

Biotechnology peers

CompanyMarket capScore
IONS Ionis Pharmaceuticals$7.3B34
PRAX Praxis Precision Medicines$7.2B45
RYTM Rhythm Pharmaceuticals$6.3B46
LGND Ligand Pharmaceuticals$6.1B64
BLTE Belite Bio$6.1B42
IMVT Immunovant$6.0B40

Questions

What is IOVA's stock score today?

IOVA scores 52/100 (Neutral) as of Oct 22, 2026: technical 65, fundamental 39, and news sentiment 45, which is shown but not counted. Scores are recomputed every night.

Is IOVA a buy?

The score is not a buy or sell recommendation. A 52 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the IOVA score calculated?

102 weighted scorers feed it today: 40 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.